06 May 2021 09:09 AM

RDIF, Minapharm agree to produce million doses of the Sputnik V ‎vaccine in Egypt

Thursday، 22 April 2021 - 02:01 PM

The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) and Egypt's Minapharm, the regional leader in recombinant DNA technology, and its Berlin-based subsidiary, ProBioGen AG, announced an agreement to produce over 40 million doses per year of the world's first registered vaccine against COVID-19, Sputnik news agency reported.


The parties intend to commence technology transfer immediately.


The rollout of the vaccine is expected in 3Q 2021.


Related Stories

Most Visited

From To